Company

Last deal

Amount

Seed

Stage

01.04.2008

Date

1

all rounds

General

About Company
Auralis develops generic drugs for critical care and pediatrics, targeting niche markets.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

Auralis developed generic pharmaceutical products for niche markets, which were subject to licence or regulatory approval providing barriers to entry to protect margin and revenue.
Contacts

location

Phone number

Social url